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Abstract 
We investigated the mechanisms whereby a previous attack of experimental autoimmune 
encephalomyelitis (EAE) modifies a subsequent attack in the Lewis rat. Active immunization with 
myelin basic protein (MBP) and complete Freund’s adjuvant 28 days after the passive transfer of 
MBP-sensitized spleen cells induced a second episode of EAE, which occurred earlier than in 
naive control animals, but was less severe overall. The pattern of neurological signs was also 
different in rechallenged rats, which had less severe tail and hindlimb weakness but more severe 
forelimb weakness. In rechallenged rats, inflammation was more severe in the cervical spinal cord, 
cerebellum, brainstem and cerebrum, but less severe in the lumbar spinal cord, than in controls. 
The early onset of EAE in rechallenged rats was explained by a memory T cell response to MBP72–
89 in the draining lymph node and spleen, and by the enhanced entry of T cells into the central 
nervous system (CNS). However, the number of αβ T cells in the spinal cord of rechallenged rats 
declined faster than in controls, especially in the lumbosacral cord, where the number of Vβ8.2+ T 
cells and the frequency of T cells reactive to MBP72–89 rapidly decreased, indicating rapid 
downregulation of the immune response in the previously inflamed spinal cord. Apoptosis of 
inflammatory cells in the CNS was increased in the rechallenged rats and is likely to contribute to 
this downregulation. Furthermore, during the disease course the generation of encephalitogenic T 
cells in the peripheral lymphoid organs was limited compared with controls. Thus, a previous 
attack of EAE modifies a subsequent attack through the interaction of the following processes: a 
memory T cell response to MBP; facilitated T cell entry into the CNS; downregulation of the 
immune response in the CNS, including increased apoptosis of inflammatory cells; and a limited 
generation of encephalitogenic T cells in the peripheral lymphoid organs.  
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1. Introduction 
 
Experimental autoimmune encephalomyelitis (EAE) is a T-cell-mediated autoimmune demyelinating 
disease of the central nervous system (CNS) that serves as an animal model of the human inflammatory 
demyelinating disease, multiple sclerosis (Pender, 1995). Acute EAE can be induced in the Lewis rat 
by active immunization with myelin basic protein (MBP) and complete Freund’s adjuvant, or by the 
passive transfer of MBP-sensitized lymphocytes. The rats develop stereotyped neurological signs with 
a predictable temporal profile: ascending tail paralysis followed by hindlimb weakness and 
occasionally forelimb weakness (Pender, 1986). They rapidly and spontaneously recover so that by 
about 7 days after the onset of neurological signs there is no residual weakness. The process of 
spontaneous recovery is not yet fully understood and many factors have been postulated to play a role, 
including endogenous corticosteroids (Levine et al., 1980; MacPhee et al., 1989), suppressor cells 
(Swierkosz and Swanborg, 1975; Welch et al., 1980) and nitric oxide (O’Brien et al., 1999). 
Furthermore, during clinical recovery there is apoptosis of inflammatory cells in the CNS (Pender et 
al., 1991), which involves T cells (Pender et al., 1992; Schmied et al., 1993), B cells (White et al., 
2000), macrophages (Nguyen et al., 1994; White et al., 1998a) and microglia (White et al., 1998a) and 
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contributes to the resolution of inflammation in the CNS. Within the T cell population in the CNS, the 
apoptotic process selectively eliminates Vβ8.2+ MBP72–89-reactive T cells (Tabi et al., 1994, 1995; 
McCombe et al., 1996), which constitute the predominant encephalitogenic MBP-reactive T cell 
population in the Lewis rat (Imrich et al., 1995). 
 
After recovery from an episode of actively induced EAE, Lewis rats have generally been found to be 
resistant to the active reinduction of disease (Willenborg, 1979; Levine and Sowinski, 1980; Hinrichs et 
al, 1981) and either resistant (Levine and Sowinski, 1980) or susceptible (Willenborg, 1979;  Hinrichs 
et al., 1981) to passively induced EAE. Rats that have recovered from passively induced EAE have 
been found by some authors to be fully susceptible to the active or passive reinduction of disease 
(Hinrichs et al., 1981) and by others to be resistant to reinduction by active (Welch et al., 1980;  
Namikawa et al., 1986) or passive means (Levine et al., 1967). Various mechanisms have been 
postulated to account for the resistance to reinduction of EAE, especially suppressor cells (Swierkosz 
and Swanborg, 1975; Welch et al., 1980; and Sun et al., 1988), but little attention has been given to the 
role of downregulatory factors within the target organ, the CNS, in the rechallenged animals. Target 
organ resistance has been demonstrated after recovery from another autoimmune disease, experimental 
autoimmune oophoritis (Lou et al., 1995), and appears to be responsible for the resistance to induction 
of even the first episode of EAE in AO rats (Mostarica-Stojkovic et al., 1992). Histological 
examination of the CNS during a mild or subclinical second attack of EAE induced in convalescent 
Lewis rats has revealed that inflammation is decreased in the spinal cord but enhanced in the 
cerebellum after rechallenge (Levine et al., 1967; Levine and Sowinksi, 1980). The authors concluded 
that alterations in the distribution of CNS lesions could be explained, not by systemic factors, but by 
local factors within the target organ. 
 
In the present study, we immunized Lewis rats with MBP in complete Freund’s adjuvant after they had 
recovered from an episode of passively induced EAE and thereby induced a second episode of EAE, 
which was less severe overall and occurred earlier than in actively immunized naive control animals. 
Although tail and hindlimb weakness was less severe, forelimb weakness was more severe in the 
rechallenged than the control rats. We hypothesized that changes within the CNS, induced by the first 
episode of EAE, might explain this redistribution of neurological signs and the overall milder clinical 
course. To investigate this, we utilized two-colour flow cytometry, histological studies and limiting 
dilution analysis to compare the inflammatory process in the lumbosacral spinal cord and 
cervicothoracic cord in actively induced EAE in naive rats and in rechallenged rats. Our results indicate 
that the outcome of active rechallenge in convalescent Lewis rats is determined by the interaction of the 
following mechanisms: a memory T cell response to MBP; facilitated T cell entry into the CNS; 
downregulatory mechanisms in the CNS, including increased apoptosis of inflammatory cells; and a 
limited generation of encephalitogenic T cells in the peripheral lymphoid organs. 
 
2. Materials and methods 
 
2.1. Animals 
Lewis rats (JC strain), 7–10 weeks old, were obtained from the Central Animal Breeding House of the 
University of Queensland.  
 
2.2. Antigens 
Whole myelin basic protein (MBP) was prepared from guinea-pig brains by the method of Deibler et 
al. (1972). The major encephalitogenic region of guinea-pig MBP in the Lewis rat, MBP peptide 72–89 
(PQKSQRSQDENPVVHF) (Offner et al., 1987), and the encephalitogenic rat MBP peptide 87–99 
(VHFFKNIVTPRTP) (Offner et al., 1989) were synthesized by Auspep Pty. Ltd. (Australia). 
Concanavalin A was obtained from Sigma Chemical Co. (USA). 
 
2.3. Preparation of MBP inoculum and immunization of rats 
MBP in saline was emulsified in an equal volume of incomplete Freund’s adjuvant containing 4 mg/ml 
Mycobacterium butyricum. Under anaesthesia, rats were inoculated in the left hind footpad with 0.1 ml 
emulsion. The total dose of MBP was 50 µg per rat.  
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2.4. Passive transfer of EAE 
Cells for passive transfer were generated according to the method of Panitch and McFarlin (1977). 
Single-cell suspensions were prepared from the spleens of male or female rats sensitized 10 days 
previously with MBP as described above. Cells were cultured at a concentration of 2×106 cells/ml in 
RPMI 1640 supplemented with 5% fetal calf serum (FCS) (Gibco BRL, USA), 5×10−5 M 2-
mercaptoethanol (Sigma), 216 mg/l L-glutamine (Trace Biosciences Pty. Ltd., Australia), 100 IU/ml 
penicillin (Trace Biosciences), 100 µg/ml streptomycin (Trace Biosciences) and 10 mM HEPES buffer 
(Trace Biosciences). Concanavalin A was added at 2 µg/ml, and 50–100 ml cultures were incubated at 
37°C in an atmosphere of 5% CO2–95% air. Cells were harvested after 72 h and washed with saline. 
Passive EAE was induced in 7-week-old male Lewis rats by the injection of 100–150×106 viable cells 
in the lateral tail vein. Age-matched male control rats received 0.5 ml of saline in the lateral tail vein. 
Neurological signs commenced 3–4 days after passive transfer and consisted of tail and hindlimb 
weakness. The peak of clinical signs occurred 6 days after passive transfer, and all rats had completely 
recovered by 12 days after transfer. 
 
2.5. Induction of active EAE 
Twenty-five to 30 days after the passive transfer of encephalitogenic splenocytes or an injection of 
saline, all rats were actively immunized with MBP inoculum as described in Section 2.3. The rats were 
monitored for clinical signs and used for flow cytometry, histology or limiting dilution assays as 
described below.  
 
2.6. Clinical assessment of animals 
Tail, hindlimb and forelimb weakness were each graded on a scale of 0 (no weakness) to 4 (total 
paralysis) as previously described (Pender, 1986). The total clinical score was obtained by adding these 
three scores (maximum=12).  
 
2.7. Histological studies 
For both actively immunized naive control and rechallenged groups, one rat was examined 
histologically on the first day, three on the second day, and one on the third day of neurological signs. 
Under anaesthesia, the rats were perfused via the aorta with saline followed by modified Karnovsky’s 
fixative (2% paraformaldehyde–2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.3–7.4). 
Five segments of the spinal cord (fifth cervical [C5], sixth thoracic [T6], fourth lumbar [L4] and second 
and fourth sacral [S2, S4]) were removed, processed and embedded in epoxy resin. Semithin sections 
(0.5 mm) were stained with toluidine blue. The cerebrum (at the level of the optic chiasm), brainstem 
and cerebellum were embedded in HistoResin (Reichert-Jung, Germany), sectioned (1 µm), and stained 
with cresyl fast violet, as previously described (Nguyen and Pender, 1989). Apoptotic cells were 
quantified by light microscopy with a 100× oil-immersion objective and were recognized by the criteria 
of Kerr et al. (1994). Levels of inflammation in the CNS were scored based on an estimation of the 
average number of inflammatory cells per field from more than 20 observed fields of the 40× objective: 
level 0=no cells; level 1=1–5; level 2=6–10; level 3=11–20; level 4=21–40; level 5=41–60; level 6=61–
80; level 7=81–100; level 8=101–150; level 9=151–200; level 10>200 cells per field. The assessor was 
unaware of the clinical findings and of whether the specimen was derived from control or rechallenged 
rats. Although involvement of the spinal roots in the peripheral nervous system contributes to the 
neurological signs of MBP–EAE (Pender et al., 1995), we focused our attention in this study on the 
CNS involvement because it is difficult to extract sufficient inflammatory cells from the spinal roots to 
perform flow cytometry and limiting dilution assays.  
 
2.8. Isolation of T cells from the spinal cord and lymphoid organs 
After active immunization, groups of control or rechallenged rats were sacrificed and T cells from the 
spinal cords, draining popliteal lymph nodes and spleens were isolated and analyzed using flow 
cytometry and limiting dilution assays as described below. Spinal cord inflammatory cells were 
extracted as previously described (Tabi et al., 1994), except that in this study the vertebral column was 
split between the T7 and T8 vertebrae into rostral and caudal regions. Single-cell suspensions were 
prepared from the draining left popliteal lymph node and spleen by teasing apart the tissues and passing 
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them through a fine nylon mesh. Erythrocytes were removed from the spleen cell suspension using 
Ficoll-paque (Pharmacia LKB Biotechnology, Sweden). To enrich for T lymphocytes, the spinal cord, 
spleen and lymph node cells were passed through a nylon wool column, as previously described (Tabi 
et al., 1994). 
 
2.9. Phenotypic and DNA analysis by flow cytometry 
Mouse monoclonal antibodies specific for the αβ T cell receptor (TCR) (R73) were obtained from Dr 
J.D. Sedgwick (DNAX Research Institute, Palo Alto, CA, USA). Mouse monoclonal antibody to Vβ8.2 
(R78) was provided by Dr T. Hünig (Torres-Nagel et al., 1993). Mouse polyclonal IgG1κ (Dako, USA) 
was used as a control antibody. The secondary antibody was fluorescein isothiocyanate (FITC)-
conjugated sheep F(ab′)2 anti-mouse IgG (Sigma). The primary and secondary antibodies were diluted 
in phosphate-buffered saline (PBS)–azide (1% FCS–1% sodium azide in PBS) plus 10% autologous rat 
serum. Cells were first washed with a 1:1 solution of FCS in PBS containing 0.1% sodium azide and 
then incubated with the primary antibodies for 30 min at 4°C. Cells were then washed, incubated with 
the secondary antibody for 30 min at 4°C in the dark, and washed twice with PBS. Samples were 
resuspended in 1 ml ice-cold 50% ethanol and fixed overnight at 4°C in the dark. The ethanol was 
removed by washing the cells with PBS, and the cells were resuspended in 100–300 µl of propidium 
iodide (PI)-staining solution which was freshly prepared by diluting stock solution (5 mg/ml RNase–
250 µg/ml PI in 0.01 M PBS containing 0.1 mM EDTA, pH 7.4) 1:4 with PBS containing 0.1% sodium 
azide. Samples were analyzed using a FACScan or FACSCalibur and CellQuest software (Becton 
Dickinson, USA), as previously described (White et al., 1998b).  
 
Using two-colour flow cytometry we analyzed T-cell-enriched cell populations isolated from the 
spleens, draining popliteal lymph nodes and lumbosacral and cervicothoracic spinal cords of groups of 
control rats 11–14 days after active immunization and of groups of rechallenged rats 6–9 days after 
active immunization, and determined the proportions of TCRαβ+, Vβ8.2+ and apoptotic cells. Each 
group consisted of 4–6 rats, and results were obtained from 3 to 5 groups on each of the days studied, 
except for day 13 for controls when results were obtained from only one group of six rats.  
 
2.10. Limiting dilution analysis 
We used limiting dilution analysis (Tabi et al., 1995) to determine the frequencies of T cells reactive to 
MBP, MBP72–89 and MBP87–99 in the lumbosacral spinal cords, cervicothoracic spinal cords, draining 
popliteal lymph nodes and spleens of control and rechallenged rats. Cells were prepared as described 
under Section 2.8. The culture medium used for this assay was RPMI 1640 supplemented with 216 
mg/l L-glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin, 0.1 mM sodium pyruvate, non-
essential amino acids, 36 mg/l L-asparagine, 5×10−5 M 2-mercaptoethanol, 10 mM HEPES buffer, 5 
µg/ml fungizone and 5% heat-inactivated FCS. Twenty-four replicates of increasing numbers of 
responder T cells (4–6 dilution steps) prepared from the spinal cord, draining lymph node or spleen, 
and 5×105 irradiated normal rat thymocytes were incubated with 15 µg/ml MBP, 10 µg/ml MBP72–89 or 
10 µg/ml MBP87–99 in 96-well U-bottomed tissue culture trays. All wells were supplemented with 10 
U/ml recombinant human interleukin-2 (IL-2) (TECIN™, kindly provided by Hoffmann-La Roche 
Inc., USA) 24 h after the commencement of the assay, and incubated for 7 days in 5% CO2–95% air at 
37°C. [3H]thymidine (0.5 µCi) was added to the wells for the last 12 h of culture. The cells were 
harvested and assayed for incorporated radioactivity. Stimulated wells were scored as positive if the 
thymidine incorporation was more than twice the mean background level (dilutions of T cells incubated 
with thymocytes in the absence of antigens), i.e. when the stimulation index was >2.0. The frequencies 
of specifically responding cells were determined as previously described (Tabi et al., 1995). The limit 
of sensitivity of the assay was 6.7×10−6 (1/150000).  
 
Limiting dilution analysis was used to determine precursor frequencies in T-cell-enriched populations 
isolated from the spleens and draining popliteal lymph nodes of control rats 5 and 9 days after active 
immunization, and rechallenged rats 5 days after active immunization. These time points were chosen 
so that we could compare the peripheral lymphoid organ T cell responses in naive and rechallenged rats 
at the same time after active immunization and just before the onset of neurological signs. In a second 
set of experiments, limiting dilution analysis was used to determine precursor frequencies in T cell 
populations from the lumbosacral spinal cords, cervicothoracic spinal cords, spleens and draining 
popliteal lymph nodes of control rats 11 and 13 days after immunization and of rechallenged rats 6 and 
8 days after immunization.  
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2.11. Statistical analysis 
Statistical analysis was performed using either a homoscedastic t-test or a heteroscedastic t-test, 
depending on the result of the F-test.  
 
 
Fig. 1. Mean total clinical scores (A) and mean clinical scores for the tail (B), hindlimbs (C) and forelimbs (D) of 
rechallenged and control rats after immunization with MBP and complete Freund’s adjuvant. The maximal mean 
total clinical score of rechallenged rats on day 8 was significantly different from that of control rats on day 14 after 
immunization (P=0.0006). Maximal mean tail score of rechallenged rats on day 8 vs. control rats on day 14, 
P=0.0005; maximal mean hindlimb score of rechallenged rats on day 7 vs. control rats on day 14, P=6.7×107−; 
maximal mean forelimb score of rechallenged rats on day 8 vs. control rats on day 15, P=0.097. 
 
3. Results 
3.1. Clinical findings 
 
As shown in Fig. 1, rechallenged animals developed EAE earlier than controls. The mean day of onset 
of neurological signs for rechallenged rats was 6.1 days after active immunization compared with 10.2 
in controls (P=4.1×10−11). The maximal mean total clinical score (peak of neurological signs) occurred 
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8 days after immunization (day 8) in rechallenged rats and on day 14 in controls. However, 
rechallenged rats were relatively resistant to this second attack of EAE. The mean total clinical score at 
the peak of disease for rechallenged rats was significantly lower than that of control animals (Fig. 1A). 
Clinical signs in control rats were typical of an episode of acute EAE: ascending paralysis, severely 
affecting the tail and hindlimbs but only occasionally involving the forelimbs. However, neurological 
signs in rechallenged rats did not follow a typical ascending course but predominantly involved the tail 
and forelimbs, with the hindlimbs often totally unaffected. In rechallenged rats the severity of tail 
weakness, and more particularly of hindlimb weakness, was significantly less than in controls (Fig. 1B, 
C), whereas the forelimbs were more severely affected, although the difference was not statistically 
significant (Fig. 1D). Occasionally, rechallenged rats developed a head tilt, emphasizing the rostral 
redistribution of neurological signs. 
 
3.2. Histological findings 
Histological studies demonstrated that, early in the clinical course, inflammation was more severe in 
the cervical spinal cord than in the lumbar spinal cord in rechallenged rats, whereas in control rats the 
lumbar cord was more severely affected (Table 1 and Fig. 2 A–D). Furthermore, even on the first day 
of neurological signs in rechallenged rats, lesions were detected in the cervical spinal cord, cerebellum 
(Fig. 3B), brainstem and cerebrum as well as in the lumbar spinal cord (Table 1). In contrast, during the 
first 2 days of neurological signs in controls, there was minimal inflammation in the cervical spinal 
cord and brainstem and no inflammation in the cerebrum and cerebellum (Table 1 and Fig. 3A). There 
were more apoptotic cells in the parenchyma of the lumbosacral cord in rechallenged rats (Fig. 3C) 
than in controls, despite the fact that there were fewer inflammatory cells (Table 1). Histological 
studies of rats with passively transferred EAE, without active rechallenge, demonstrated that there was 
no residual inflammation in the spinal cord or brain 35 days after transfer, at a time when the 
rechallenged rats showed prominent inflammation in the CNS. 
  
TABLE 1. Histological findings 
 
L4 C5 Group of 
rats 
Day of 
neuro-
logical 
signs 
Number 
of rats 
Inflammat- 
ion scoreb 
Number 
of 
apoptotic 
cellsc 
Inflammat
-ion score 
Number  
of 
apoptotic 
cells 
Cerebellum 
Inflammat-
ion score  
Brainstem 
Inflammat-
ion score  
Cerebrum 
Inflammat-
ion score 
Controls 1 (10)a 
2 (11.3) 
3(13) 
1 
3 
1 
1 
5±1 
6 
0 
3±1 
13 
1 
1±0 
6 
0 
0 
7 
0 
0 
0 
1 
1±0 
2 
0 
0 
0 
Re-
challenged 
1 (6) 
2 (6.7) 
3 (7) 
1 
3 
1 
3 
3±1 
3 
14 
14±6 
18 
10 
9±1 
9 
81 
84±10 
54 
4 
2±2 
2 
3 
4±1 
3 
3 
3±1 
2 
 
a Number of days after active immunization. 
b Inflammation in the meninges and parenchyma was graded on a scale of 0 (no inflammatory cells 
present) to 10 (severe inflammation). 
c The number of apoptotic cells in the parenchyma of the whole transverse section. 
 
Journal of Neuroimmunology (2001) 112 (1-2): 15-27.             doi: 10.1016/S0165-5728(00)00341-6     
 
 
 
Fig. 2. Light micrographs of: (A) the lumbar spinal cord of an actively immunized naive control rat on the second 
day of neurological signs, showing numerous inflammatory cells (arrows) in the parenchyma; (B) the lumbar 
spinal cord of a rechallenged rat on the second day of neurological signs, showing minimal inflammation; (C) the 
cervical spinal cord of the same control rat showing no inflammation; (D) the cervical spinal cord of the same 
rechallenged rat showing numerous inflammatory cells throughout the parenchyma. Epoxy resin sections (0.5 µm) 
stained with toluidine blue. Bar=100 µm. 
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Fig. 3. (A, B) Light micrographs of the cerebellar white matter of (A) an actively immunized naive control rat on 
the second day of neurological signs and of (B) a rechallenged rat on the first day of neurological signs, showing 
no inflammation in the former and prominent inflammation in the latter. (C) Light micrograph of the lumbar spinal 
cord of a rechallenged rat on the second day of neurological signs showing frequent apoptotic cells (arrows) in a 
minimally inflamed parenchyma. (A) and (B) HistoResin sections (1 µm) stained with cresyl fast violet; (C) epoxy 
resin section (0.5 µm) stained with toluidine blue. Bars: (A) & (B)=100 µm; (C)=10 µm. 
 
3.3. Flow cytometric studies of the spinal cord 
The numbers of total inflammatory cells and TCRαβ+ T cells isolated from the cervicothoracic cord in 
rechallenged rats on day 6 were higher than in control rats on days 11 (P=0.004 and 0.13, respectively) 
and 12 (P=0.03 and 0.046, respectively) (Fig. 4A–D), indicating enhanced entry of T cells. In controls, 
the numbers of total inflammatory cells, TCRαβ+ T cells and Vβ8.2+ T cells isolated from the 
cervicothoracic cord were significantly lower than those isolated from the lumbosacral cord on each of 
the days studied (P<0.05), except for Vβ8.2+ T cells on day 12 (P=0.07) (Fig. 4A, C, E). In contrast, 
throughout the disease episode in rechallenged animals, the numbers of total inflammatory cells, 
TCRαβ+ T cells and Vβ8.2+ T cells isolated from the cervicothoracic spinal cord were not significantly 
different from those extracted from the lumbosacral cord (P>0.05) (Fig. 4B, D, F). It is also clear from 
Fig. 4 that, whereas the numbers of total inflammatory cells and TCRαβ+ T cells in the spinal cord 
increased early in the clinical course in controls, they began to decline on day 7, the day after the onset 
of neurological signs, in rechallenged animals. This decline was more dramatic in the lumbosacral 
cord. On day 9, only 22% of the number of total inflammatory cells present in the lumbosacral cord on 
day 6 remained, but in the cervicothoracic cord the corresponding percentage was 52%. In contrast to 
controls, there was also a rapid decline in the number of Vβ8.2+ T cells in the spinal cord, particularly 
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the lumbosacral cord, of rechallenged rats over the first 2 days of neurological signs (Fig. 4E, F). The 
number of Vβ8.2+ T cells in the lumbosacral cord was much lower in rechallenged rats than in controls.  
 
 
 
 
Fig. 4. The numbers of total inflammatory cells, TCRαβ+ T cells and Vβ8.2+ T cells extracted from the 
lumbosacral and cervicothoracic spinal cord of control rats (A, C, E), 11–14 days, and rechallenged rats (B, D, F) 
6–9 days after immunization with MBP in complete Freund’s adjuvant. On each of the days studied, results were 
obtained from 3 to 5 groups, consisting of 4–6 rats, except for day 13 for the controls when results were obtained 
from only one group of 6 rats.  
 
The proportions of TCRαβ+ T cells in both the lumbosacral spinal cord (60.1±6.0) and cervicothoracic 
spinal cord (59.7±5.8) on day 6 in rechallenged rats were higher than in control rats on day 11 
(41.2±4.5 and 38.8±6.3, respectively) and on all of the other days tested. However, in the lumbosacral 
cord of rechallenged rats this proportion dropped rapidly to be the same as in controls within 24 h after 
the onset of neurological signs. The proportions of Vβ8.2+ T cells in the CNS infiltrate were generally 
lower in rechallenged rats than in controls, and as a result there was a marked difference, in the 
proportion of TCRαβ+ T cells that were Vβ8.2+, between control and rechallenged groups (Fig. 5). 
Vβ8.2+ T cells constituted 6–9% of the TCRαβ+ T cell population in the spinal cord in rechallenged rats 
(Fig. 5B) compared with 14–17% in control rats (Fig. 5A), with the exception of the results from the 
cervicothoracic cord on day 13 in the latter group.  
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Fig. 5. Vβ8.2+ T cells as a proportion of the TCRαβ+ T cells in the lumbosacral spinal cord, cervicothoracic spinal 
cord, spleen and draining lymph node of control (A) and rechallenged rats (B).  
 
The levels of apoptosis in the spinal cord infiltrate early in the clinical course were higher in 
rechallenged (Fig. 6B) than control rats (Fig. 6A). The highest percentage of apoptotic cells was 
detected on day 6 in the lumbosacral cord of rechallenged rats. We did not detect differences in the 
proportions of TCRαβ+ cells or Vβ8.2+ T cells that were apoptotic between control and rechallenged 
groups. There was also no significant difference in the enrichment of Vβ8.2+ T cells in the apoptotic 
TCRαβ+ population between control and rechallenged rats.  
 
3.4. Phenotypic analysis of draining lymph node and spleen cells 
The proportions of TCRαβ+ T cells that were Vβ8.2+ in the spleen and draining lymph node were 
similar in the control and rechallenged rats and were in the range of 4–8% (Fig. 5). Therefore, in 
actively induced EAE in control rats, Vβ8.2+ T cells are highly enriched in the inflammatory infiltrate 
in the spinal cord compared to the peripheral lymphoid organs, whereas in rechallenged rats there is 
only a slight enrichment of Vβ8.2+ T cells in the spinal cord infiltrate.  
 
3.5. Limiting dilution analysis 
As shown in Table 2, rechallenged rats exhibited a memory T cell response to immunization so that the 
frequencies of MBP-reactive T cells and MBP72–89-reactive T cells in the draining lymph node of 
rechallenged rats 5 days after active immunization were comparable to the frequencies present in the 
draining lymph node of control rats on day 9. The memory T cell response in rechallenged rats was 
also reflected in the spleen, where the frequencies of MBP-reactive T cells and MBP72–89-reactive T 
cells on day 5 were significantly higher than in control groups on days 5 and 9. 
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Fig. 6. The percentages of apoptotic cells in the inflammatory infiltrate isolated from the lumbosacral and 
cervicothoracic spinal cord of control and rechallenged rats. Lumbosacral spinal cord: rechallenged day 6 vs. 
controls day 11, P=0.003; rechallenged day 6 vs. controls day 12, P=0.007; rechallenged day 6 vs. controls day 14, 
P=0.004. Cervicothoracic spinal cord: rechallenged day 6 vs. controls day 11, P=0.03; rechallenged day 6 vs. 
controls day 12, P=0.28; rechallenged day 6 vs. controls day 14, P=0.30.  
  
TABLE 2. Frequencies of MBP-, MBP72–89 - and MBP87–99 -reactive T cells in the peripheral lymphoid 
organs 
 
Draining popliteal lymph node Spleen cells Group of 
rats 
Days after 
active 
immunizat-
ion 
Number of rats 
(number of 
experiments) MBP MBP72–89 MBP87–99 MBP MBP72–89 MBP87–99 
Controls 5 
 
 
9 
 
 
11 
 
 
13 
 
13 (5)a 
 
 
9 (3) 
 
 
7 (1) 
 
 
6(1) 
11b 
(7-23)c 
 
20 
(12-35) 
 
46 
(35-60) 
 
524 
(386-712) 
<7 
 
 
22 
(15-35) 
 
46 
(35-61) 
 
151 
(115-198) 
<7 
 
 
<7 
 
 
<7 
 
 
<7 
<7 
 
 
<7 
 
 
39 
(29-52) 
 
228 
(172-302) 
<7 
 
 
<7 
 
 
82 
(63-108) 
 
88 
(67-115) 
<7 
 
 
<7 
 
 
<7 
 
 
<7 
Re-
challenged 
5 
 
 
6 
 
 
8 
13 (5)a 
 
 
7 (1) 
 
 
8 (1) 
23 
(13-40) 
 
58 
(44-76) 
 
101 
(76-133) 
11 
(5-24) 
 
11 
(7-16) 
 
54 
(38-75) 
<7 
 
 
<7 
 
 
<7 
31 
(20-49) 
 
80 
(60-106) 
 
38 
(23-61) 
60 
(45-80) 
 
33 
(22-48) 
 
35 
(22-56) 
<7 
 
 
<7 
 
 
27 
(16-46) 
 
 
a Precursor frequencies in the spleen on day 5 were determined from a total of 11 animals in four experiments. 
b Frequency per 106 T cells. 
c 95% confidence limits. 
 
In control rats the frequencies of MBP-reactive T cells and MBP72–89-reactive T cells in the draining 
lymph node, spleen, lumbosacral spinal cord and cervicothoracic spinal cord increased between days 
11 and 13 (Table 2 and Table 3). In the rechallenged rats the frequencies of MBP-reactive T cells and 
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MBP72–89-reactive T cells increased in the draining lymph node from days 5 to 8, decreased in the 
lumbosacral cord from days 6 to 8 and increased in the cervicothoracic cord from days 6 to 8 (Table 2 
and Table 3). This early decrease in the frequency of MBP72–89-reactive T cells in the lumbosacral cord 
corresponds with the rapid loss of Vβ8.2+ T cells from this region of the spinal cord (Fig. 4F) and is 
further evidence of rapid downregulation of the immune response in the CNS. At the peak of 
neurological signs in rechallenged animals, on day 8, the frequencies of MBP72–89-reactive T cells in 
the draining lymph node and spleen were significantly lower than in control rats on day 13 (Table 2). 
These results suggest that, although rechallenged rats demonstrated a memory T cell response, the 
generation of encephalitogenic T cells in the peripheral lymphoid organs during the disease course was 
reduced compared with that in control animals.  
 
TABLE  3. Frequencies of MBP-, MBP72–89 - and MBP87–99-reactive T cells in the spinal cord  
 
Lumbosacral spinal cord Cervicothoracic spinal cord Group of 
rats a 
Days after 
active 
immunizat-
ion 
MBP MBP72–89 MBP87–99 MBP MBP72–89  MBP87–99 
Controls 11 
 
 
13 
 
50b 
(34–74)c 
 
1261 
(949–1678) 
126 
(94–170) 
 
1000 
(755–1325) 
<7 
 
 
7 
(3–17) 
 
<7 
 
 
1131 
(855–1497) 
 
<7 
 
 
670 
(510–879) 
 
<7 
 
 
11 
(5–23) 
 
Re-
challenged 
6 
 
 
8 
890 
(675–1174) 
 
111 
(81–152) 
185 
(140–245) 
 
44  
(28–70) 
<7 
 
 
9 
(3–23) 
208 
(157–276) 
 
340 
(260–445) 
34 
(20–56) 
 
178 
(135–236) 
<7 
 
 
12 
(6–24) 
 
 a Same groups as presented in Table 2. 
b Frequency per 106 T cells. 
c 95% confidence limits. 
 
T cells reactive to MBP87–99 were detectable in the lumbosacral and cervicothoracic spinal cord of 
control rats on day 13 and in the lumbosacral and cervicothoracic spinal cord and spleen of 
rechallenged rats on day 8 (Table 2 and Table 3).  
 
3.6. Passive transfer of EAE by splenocytes from rechallenged rats 
To determine whether the immune cells from rechallenged rats could induce EAE with an altered 
pattern of neurological signs, we transferred concanavalin-A-activated splenocytes from rechallenged 
rats into naive rats. In the first experiment four rats each received 75×106 splenocytes that had been 
isolated from rechallenged rats 5 days after immunization with MBP inoculum. The recipients 
developed isolated tail weakness. In a second experiment we injected three rats with 150×106 
splenocytes isolated from rechallenged rats 6 days after immunization. These recipients developed tail 
paralysis, moderate hindlimb weakness and no forelimb weakness. We therefore concluded that EAE 
induced by immune cells from rechallenged rats follows a typical ascending course.  
 
4. Discussion 
In this study we have shown that an episode of passively transferred EAE modifies a subsequent 
actively induced attack of EAE through an interaction of the following mechanisms: a memory T cell 
response to MBP; facilitated entry of T cells into the CNS; rapid downregulation of the immune 
response in the CNS, with increased apoptosis of inflammatory cells; and a limited generation of 
encephalitogenic T cells in the peripheral lymphoid organs.  
 
Active immunization with MBP and complete Freund’s adjuvant 28 days after the passive transfer of 
MBP-sensitized spleen cells induced a second episode of EAE, which occurred earlier than in naive 
control animals, but was less severe, as previously reported (Hinrichs et al., 1981; Namikawa et al., 
1986). We also observed a redistribution of the neurological signs in the rechallenged rats, with less 
severe tail weakness and much less severe hindlimb weakness but increased forelimb weakness, 
compared to controls. Our histological studies revealed an earlier onset of inflammatory CNS lesions in 
rechallenged rats, confirming the findings of Levine and Saltzman (1991). We also found that, early in 
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the clinical course in rechallenged rats, inflammation was more severe in the cervical spinal cord than 
in the lumbar cord, whereas the opposite was the case in controls. Furthermore, inflammation was also 
more severe in the cerebellum, brainstem and cerebrum in rechallenged rats than in controls. The 
rostral redistribution of histological lesions after the reinduction of EAE has previously been reported 
(Levine et al., 1967; Willenborg, 1979; Levine and Sowinski, 1980; Namikawa et al., 1986). 
Alterations in the distribution of CNS lesions cannot be explained by systemic mechanisms but can be 
explained by local factors within the CNS. We hypothesized that changes within the CNS, induced by 
the first episode of EAE, might explain the redistribution of neurological signs and lesions and the mild 
clinical course in rechallenged rats.  
 
Limiting dilution assays of the draining popliteal lymph node and spleen revealed a memory T cell 
response to MBP and MBP72–89 in rechallenged rats. This may contribute to the early onset of EAE. 
However, a memory T cell response cannot solely explain the rapid infiltration of inflammatory cells 
into the CNS after rechallenge, because the numbers of αβ T cells and Vβ8.2+ T cells infiltrating the 
cervicothoracic spinal cord were higher 6 days after rechallenge than 13 days after active immunization 
in naive animals, despite the fact that the T cell reactivities to MBP and MBP72–89 in the draining lymph 
node and spleen were considerably higher in the latter. Therefore, it is likely that changes in the CNS 
induced by the first episode of EAE contribute to the rapid entry of inflammatory cells after 
rechallenge. Such changes may include disruption of the blood–brain barrier and the increased 
expression of adhesion molecules and chemokines.  
 
Despite the memory T cell response and the enhanced entry of inflammatory cells into the spinal cord, 
the mean total clinical score at the peak of disease was lower for rechallenged rats than controls, 
suggesting the occurrence of downregulatory mechanisms. The rapid decline in the numbers of αβ T 
cells and Vβ8.2+ T cells and in the frequencies of MBP-reactive T cells and MBP72–89-reactive T cells 
in the lumbosacral cord of the rechallenged rats indicates rapid downregulation of the immune response 
in this previously inflamed region of the spinal cord. This is likely to have contributed to the reduced 
disease in the lumbosacral cord and the reduced tail and hindlimb involvement in the rechallenged rats. 
The less intense downregulation in the cervicothoracic cord may have allowed the memory T cell 
response and increased influx of inflammatory cells to be manifested by increased cervicothoracic cord 
disease, which may have contributed to the increased forelimb weakness. Our observation that the 
passive transfer, to naive rats, of spleen cells from rechallenged rats with an altered distribution of 
neurological signs induced EAE with a standard pattern of neurological signs without redistribution is 
further evidence that this modulation of the immune response in rechallenged rats is occurring in the 
previously inflamed CNS and is not a feature of the encephalitogenic T cells themselves.  
 
Our flow cytometric studies revealed that the proportion of cells undergoing apoptosis in the CNS 
inflammatory infiltrate was increased in the cervicothoracic spinal cord and particularly the 
lumbosacral cord on the day of onset of neurological signs in rechallenged rats, compared to controls. 
Our histological studies also indicated that the proportion of inflammatory cells undergoing apoptosis 
in the parenchyma of the lumbar spinal cord was higher in rechallenged rats than in control rats. This 
apoptosis is likely to contribute to the downregulation of the immune response in the spinal cord in 
rechallenged rats, as it does during the first attack of EAE (Tabi et al., 1994, 1995). Increased T cell 
apoptosis in the CNS in rechallenged rats could be due to increased activation-induced apoptosis as a 
result of increased class II major histocompatibility complex molecule expression on microglia and 
increased availability of MBP in the previously inflamed CNS, as we have recently suggested (White et 
al., 1998b). During the first attack of EAE, Vβ8.2+ T cells, which constitute the predominant 
encephalitogenic MBP-reactive T cell population in the Lewis rat (Imrich et al., 1995), selectively 
undergo apoptosis in the CNS (Tabi et al., 1994; McCombe et al, 1996). In the present study we did not 
find an increase in the selective apoptosis of Vβ8.2+ T cells in the spinal cord in rechallenged rats 
compared to controls. However, as there was only a low level of enrichment of Vβ.2+ T cells in the 
spinal cord in rechallenged rats compared to controls, it is likely that many of the Vβ8.2+ T cells in the 
CNS of rechallenged rats were not MBP-specific and would not undergo activation-induced apoptosis 
in the CNS. Moreover, rapid downregulation of the TCR after reactivation in the CNS prior to 
apoptosis may have resulted in many apoptotic Vβ8.2+ T cells being unable to be detected by antibody 
binding to Vβ8.2. This is supported by our finding that T cells expressing low levels of TCRαβ or 
Vβ8.2 were much more vulnerable to apoptosis than T cells expressing high levels of TCRαβ or Vβ8.2 
(Gordon and Pender, unpublished results).  
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Although there was a memory T cell response in the peripheral lymphoid organs in the rechallenged 
rats, the frequencies of MBP-reactive T cells and MBP72–89-reactive T cells in the draining lymph node 
at the time of maximal neurological signs were substantially lower than in controls, indicating limited 
peripheral generation of encephalitogenic T cells. This might be due to a high level of interferon-γ-
induced nitric oxide production (Ding et al., 1988) in the draining lymph node, as a result of the 
reactivation of memory T cells specific for mycobacterial antigens or MBP. Such a limited generation 
of encephalitogenic T cells in the periphery would fail to compensate for the apoptotic elimination of 
these cells in the CNS and could contribute to the lower frequency of MBP72–89-reactive T cells and 
lower proportion of Vβ8.2+ T cells in the CNS and to the overall reduction in disease severity in 
rechallenged rats.  
 
 
Acknowledgements 
This work was supported by project grants from the National Multiple Sclerosis Society of Australia 
and from the National Health and Medical Research Council of Australia. We thank Dr Thomas Hünig 
for the anti-Vβ8.2 antibody, Grace Chojnowski and Paula Hall for their assistance with the flow 
cytometry work, and Lynn Mallard for technical assistance.  
 
 
References 
Deibler, G.E., Martenson, R.E. and Kies, M.W., 1972. Large scale preparation of myelin basic protein from central 
nervous tissue of several mammalian species. Prep. Biochem. 2, pp. 139–165.   
Ding, A.H., Nathan, C.F. and Stuehr, D.J., 1988. Release of reactive nitrogen intermediates and reactive oxygen 
intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for 
independent production. J. Immunol. 141, pp. 2407–2412.    
Hinrichs, D.J., Roberts, C.M. and Waxman, F.J., 1981. Regulation of paralytic experimental allergic 
encephalomyelitis in rats: susceptibility to active and passive disease reinduction. J. Immunol. 126, pp. 1857–1862.  
Imrich, H., Kugler, C., Torres-Nagel, N., Dörries, R. and Hünig, T., 1995. Prevention and treatment of Lewis rat 
experimental allergic encephalomyelitis with a monoclonal antibody to the T cell receptor Vβ8.2 segment. Eur. J. 
Immunol. 25, pp. 1960–1964.    
Kerr, J.F.R., Winterford, C.M. and Harmon, B.V., 1994. Morphological criteria for identifying apoptosis. In: Celis, 
J.E., Editor, 1994. Cell Biology: A Laboratory Handbook, Academic Press, San Diego, pp. 319–329.  
Levine, S. and Saltzman, A., 1991. Accelerated response to reinoculation in experimental allergic 
encephalomyelitis: Histopathologic study. J. Neuropathol. Exp. Neurol. 50, pp. 126–133.    
Levine, S. and Sowinski, R., 1980. Experimental allergic encephalomyelitis. Inhibition of clinical signs and 
paradoxical enhancement of lesions in second attacks. Am. J. Pathol. 101, pp. 375–385.    
Levine, S., Hoenig, E.M. and Wenk, E.J., 1967. Altered distribution of lesions after repeated passive transfers of 
allergic encephalomyelitis. Proc. Soc. Exp. Biol. Med. 126, pp. 454–458.    
Levine, S., Sowinski, R. and Steinetz, B., 1980. Effects of experimental allergic encephalomyelitis on thymus and 
adrenal: Relation to remission and relapse. Proc. Soc. Exp. Biol. Med. 165, pp. 218–224.    
Lou, Y.-H., McElveen, F., Adams, S. and Tung, K.S.K., 1995. Altered target organ. A mechanism of postrecovery 
resistance to murine autoimmune oophoritis. J. Immunol. 155, pp. 3667–3673.  
MacPhee, I.A., Antoni, F.A. and Mason, D.W., 1989. Spontaneous recovery of rats from experimental allergic 
encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. 
Med. 169, pp. 431–445.  
McCombe, P.A., Nickson, I., Tabi, Z. and Pender, M.P., 1996. Apoptosis of Vβ8.2+ T lymphocytes in the spinal 
cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with 
myelin basic protein. J. Neurol. Sci. 139, pp. 1–6.  
Mostarica-Stojkovic, M., Vukmanovic, S., Ramic, Z. and Lukic, M.L., 1992. Evidence for target tissue regulation 
of resistance to the induction of experimental allergic encephalomyelitis in AO rats. J. Neuroimmunol. 41, pp. 97–
104.  
Namikawa, T., Kunishita, T. and Tabira, T., 1986. Modulation of experimental allergic encephalomyelitis (EAE): 
Suppression of active reinduction of EAE in rats recovered from passively transferred disease. J. Neuroimmunol. 
12, pp. 235–245.    
Nguyen, K.B. and Pender, M.P., 1989. Assessment of demyelination in glycol methacrylate sections: A new 
protocol for cresyl fast violet staining. Stain Technol. 64, pp. 163–167.    
Journal of Neuroimmunology (2001) 112 (1-2): 15-27.             doi: 10.1016/S0165-5728(00)00341-6     
Nguyen, K.B., McCombe, P.A. and Pender, M.P., 1994. Macrophage apoptosis in the central nervous system in 
experimental autoimmune encephalomyelitis. J. Autoimmun. 7, pp. 145–152.  
O’Brien, N.C., Charlton, B., Cowden, W.B. and Willenborg, D.O., 1999. Nitric oxide plays a critical role in the 
recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to 
reinduction. J. Immunol. 163, pp. 6841–6847.  
Offner, H., Hashim, G. and Vandenbark, A.A., 1987. Response of rat encephalitogenic T lymphocyte lines to 
synthetic peptides of myelin basic protein. J. Neurosci. Res. 17, pp. 344–348.    
Offner, H., Hashim, G.A., Celnik, B., Galang, A., Li, X.B., Burns, F.R., Shen, N., Heber-Katz, E. and Vandenbark, 
A.A., 1989. T cell determinants of myelin basic protein include a unique encephalitogenic I-E-restricted epitope 
for Lewis rats. J. Exp. Med. 170, pp. 355–367.  
Panitch, H.S. and McFarlin, D.E., 1977. Experimental allergic encephalomyelitis: enhancement of cell-mediated 
transfer by concanavalin A. J. Immunol. 119, pp. 1134–1137.    
Pender, M.P., 1986. Ascending impairment of nociception in rats with experimental allergic encephalomyelitis. J. 
Neurol. Sci. 75, pp. 317–328.  
Pender, M.P., 1995. Experimental autoimmune encephalomyelitis. In: Pender, M.P. and McCombe, P.A., Editors, 
1995. Autoimmune Neurological Disease, Cambridge University Press, Cambridge, pp. 26–88.  
Pender, M.P., Nguyen, K.B., McCombe, P.A. and Kerr, J.F.R., 1991. Apoptosis in the nervous system in 
experimental allergic encephalomyelitis. J. Neurol. Sci. 104, pp. 81–87.  
Pender, M.P., McCombe, P.A., Yoong, G. and Nguyen, K.B., 1992. Apoptosis of αβ T lymphocytes in the nervous 
system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired 
tolerance. J. Autoimmun. 5, pp. 401–410.  
Pender, M.P., Tabi, Z., Nguyen, K.B. and McCombe, P.A., 1995. The proximal peripheral nervous system is a 
major site of demyelination in experimental autoimmune encephalomyelitis induced in the Lewis rat by a myelin 
basic protein-specific T cell clone. Acta Neuropathol. (Berl.) 89, pp. 527–531.  
Schmied, M., Breitschopf, H., Gold, R., Zischler, H., Rothe, G., Wekerle, H. and Lassmann, H., 1993. Apoptosis 
of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a 
mechanism to control inflammation in the brain. Am. J. Pathol. 143, pp. 446–452.    
Sun, D., Qin, Y., Chluba, J., Epplen, J.T. and Wekerle, H., 1988. Suppression of experimentally induced 
autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 332, pp. 843–845.  
Swierkosz, J.E. and Swanborg, R.H., 1975. Suppressor cell control of unresponsiveness to experimental allergic 
encephalomyelitis. J. Immunol. 115, pp. 631–633.    
Tabi, Z., McCombe, P.A. and Pender, M.P., 1994. Apoptotic elimination of Vβ8.2+ cells from the central nervous 
system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of 
Vβ8.2+ encephalitogenic T cells. Eur. J. Immunol. 24, pp. 2609–2617.  
Tabi, Z., McCombe, P.A. and Pender, M.P., 1995. Antigen-specific down-regulation of myelin basic protein-
reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: Further evidence 
of apoptotic deletion of autoreactive T cells in the central nervous system. Int. Immunol. 7, pp. 967–973.    
Torres-Nagel, N.E., Gold, D.P. and Hünig, T., 1993. Identification of rat TCR β-V8.2, 8.5, and 10 gene products 
by monoclonal antibodies. Immunogenetics 37, pp. 305–308.    
Welch, A.M., Holda, J.H. and Swanborg, R.H., 1980. Regulation of experimental allergic encephalomyelitis. II. 
Appearance of suppressor cells during the remission phase of the disease. J. Immunol. 125, pp. 186–189.  
White, C.A., McCombe, P.A. and Pender, M.P., 1998. Microglia are more susceptible than macrophages to 
apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not 
involving Fas (CD95). Int. Immunol. 10, pp. 935–941.  
White, C.A., McCombe, P.A. and Pender, M.P., 1998. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in 
the central nervous system in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 82, pp. 47–55.  
White, C.A., Nguyen, K.B. and Pender, M.P., 2000. B cell apoptosis in the central nervous system in experimental 
autoimmune encephalomyelitis: roles of B cell CD95, CD95L and Bcl-2 expression. J. Autoimmun. 14, pp. 195–
204.  
Willenborg, D.O., 1979. Experimental allergic encephalomyelitis in the Lewis rat: Studies on the mechanism of 
recovery from disease and acquired resistance to reinduction. J. Immunol. 123, pp. 1145–1150.  
 
 
 
